These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33607140)

  • 1. Development of a naftopidil-chitosan-based fumaric acid solid dispersion to improve the dissolution rate and stability of naftopidil.
    Sohn JS; Kim JS; Choi JS
    Int J Biol Macromol; 2021 Apr; 176():520-529. PubMed ID: 33607140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats.
    Choi JS; Byeon JC; Park JS
    Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():264-274. PubMed ID: 30573249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo.
    Huang JJ; Cai Y; Yi YZ; Huang MY; Zhu L; He F; Liu XW; Huang BY; Yuan M
    Eur J Pharmacol; 2016 Nov; 791():473-481. PubMed ID: 27615445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of tadalafil using a tartaric acid and chitosan-based multi-system.
    Sohn JS; Choi JS
    Int J Biol Macromol; 2021 Jan; 168():866-874. PubMed ID: 33249149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumaric acid microenvironment tablet formulation and process development for crystalline cenicriviroc mesylate, a BCS IV compound.
    Menning MM; Dalziel SM
    Mol Pharm; 2013 Nov; 10(11):4005-15. PubMed ID: 23941629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiospecific determination of naftopidil by RRLC-MS/MS reveals stereoselective pharmacokinetics and tissue distributions in rats.
    Liu X; Zhang X; Huang J; Rong Y; Luo C; Guo J; Zhu L; Huang B; Yuan M
    J Pharm Biomed Anal; 2015 Aug; 112():147-54. PubMed ID: 25985066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of rapidly dissolving buccal films of naftopidil:
    Elagamy HI; Essa EA; Nouh A; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1695-1706. PubMed ID: 31418592
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous stereoselective analysis of naftopidil and O-desmethyl naftopidil enantiomers in rat feces using an online column-switching high-performance liquid chromatography method.
    Zhang YY; Liu XW; Zhu LJ; Yuan M
    Biomed Chromatogr; 2014 Jul; 28(7):1030-5. PubMed ID: 24420149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor and enantioselective bioavailability of naftopidil enantiomers is due to extensive and stereoselective metabolism in rat liver.
    Liu X; Zhu L; Huang B; Huang J; Cai Y; Zhu L; Wu B; Fu X; Zhang X; Rong Y; Xiao Q; Guo J; Li A; Guo Y; Yuan M
    J Pharm Biomed Anal; 2017 Jan; 132():165-172. PubMed ID: 27744175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of the in vivo-in vitro correlation of the naftopidil sustained-release tablet in dog].
    Jia Y; Jiang X; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):826-8, 843. PubMed ID: 17002117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of chitosan with monomethyl fumaric acid in an ionic liquid solution.
    Wang Z; Zheng L; Li C; Zhang D; Xiao Y; Guan G; Zhu W
    Carbohydr Polym; 2015 Mar; 117():973-979. PubMed ID: 25498724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Coenzyme Q10 solid dispersion for improved solubilization and stability.
    Choi JS; Park JW; Park JS
    Int J Pharm; 2019 Dec; 572():118832. PubMed ID: 31726197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, crossover study].
    Masuda M; Jinza S; Masuko H; Asakura T; Hashiba T
    Hinyokika Kiyo; 2012 Dec; 58(12):671-8. PubMed ID: 23328162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
    Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
    Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.
    Choi JS; Park JS
    Eur J Pharm Sci; 2017 Jan; 97():269-276. PubMed ID: 27919702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil.
    Mannava MKC; Bommaka MK; Dandela R; Solomon KA; Nangia AK
    Chem Commun (Camb); 2022 May; 58(37):5582-5585. PubMed ID: 35393986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant-free solid dispersion of BCS class IV drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro - permeability increase.
    Huang R; Han J; Wang R; Zhao X; Qiao H; Chen L; Li W; Di L; Zhang W; Li J
    Eur J Pharm Sci; 2019 Mar; 130():147-155. PubMed ID: 30699368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of naftopidil enantiomers in rat plasma using chiral solid phases and pre-column derivatization high-performance liquid chromatography.
    Liu X; Zhang Y; Yuan M; Sun Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():140-5. PubMed ID: 23026227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.
    Onoue S; Inoue R; Taniguchi C; Kawabata Y; Yamashita K; Wada K; Yamauchi Y; Yamada S
    Int J Pharm; 2012 Apr; 426(1-2):61-66. PubMed ID: 22266536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.